Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients
- 28 February 2006
- journal article
- research article
- Published by Elsevier in American Journal of Infection Control
- Vol. 34 (1) , 44-48
- https://doi.org/10.1016/j.ajic.2005.07.004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Staphylococcus aureus nasal carriage and surgical-site infectionsSurgery, 2003
- Process improvement plan for the reduction of sternal surgical site infections among patients undergoing coronary artery bypass graft surgeryAmerican Journal of Infection Control, 2002
- Intranasal Mupirocin to Prevent PostoperativeStaphylococcus aureusInfectionsNew England Journal of Medicine, 2002
- Superficial and deep sternal wound complications: incidence, risk factors and mortalityEuropean Journal of Cardio-Thoracic Surgery, 2001
- The Clinical and Economic Impact of Deep Chest Surgical Site Infections Following Coronary Artery Bypass Graft SurgeryChest, 2000
- The endogenous pathway is a major route for deep sternal wound infectionEuropean Journal of Cardio-Thoracic Surgery, 2000
- Guideline for Prevention of Surgical Site Infection, 1999Infection Control & Hospital Epidemiology, 1999
- A prospective study of wound infection in coronary artery surgeryEuropean Journal of Cardio-Thoracic Surgery, 1999
- Reduction of Surgical-Site Infections in Cardiothoracic Surgery by Elimination of Nasal Carriage of Staphylococcus aureusInfection Control & Hospital Epidemiology, 1996
- The Relation between the Nasal-Staphylococcal-Carrier State and the Incidence of Postoperative ComplicationsNew England Journal of Medicine, 1959